RxSight, Inc. Reports Second Quarter 2024 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/7/2026
- Wall Street ends lower as solid jobs data fuels hawkish Fed bets
- US nonfarm payrolls blow past expectations in August; unemployment rate steady at 4.1%
- BofA's Hartnett says stay long commodities and gold as 'policy panic' works
- Oil ends week higher on renewed US-Iran strikes, diesel hits record
- TikTok owner ByteDance said to secure $29.6bn loan for AI push
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
RxSight Inc. (RXST) PT Lowered to $65 at Stifel
August 6, 2024 5:17 AM EDTStifel analyst Tom Stephan lowered the price target on RxSight Inc. (NASDAQ: RXST) to $65.00 (from $70.00) while maintaining a Buy rating.
The analyst comments "RXST shares should snap back from an inexplicably-pronounced intra-quarter sell-off--likely exasperated by a difficult med-tech tape--following a strong beat-and-raise. While... More
RxSight Inc. (RXST) PT Lowered to $59 at BTIG
August 6, 2024 4:57 AM EDTBTIG analyst Ryan Zimmerman lowered the price target on RxSight Inc. (NASDAQ: RXST) to $59.00 (from $73.00) while maintaining a Buy rating.
The analyst comments "We reiterate our Buy and adjust our PT to $59 (from $73) following 2Q24 results. RXST continues to deliver strong FY24 results with 2Q24 revenue of $34.9M (67.6% Y/Y) and adj. LPS of $0.00 above BTIG/Consensus ests. of $32.2M/$32.3M and adj. LPS of... More
